The Year In Review: Allergan (Sharewatch)
Best known for its Botox wrinkle treatment, the Irvine, Calif.-based maker of eye care and cosmetic surgery products increased its cash-only product portfolio to account for a third of revenue during the year with such new products as wrinkle-fillers and breast implants.

Business news in brief (The Philadelphia Inquirer)
U.S. regulators have cleared six more companies to begin selling generic copies of Merck & Co. Inc.'s cholesterol drug Zocor, signaling steeper price reductions. The approvals posted on the Food and Drug Administration's Web site yesterday are in addition to those granted Teva Pharmaceutical Industries Ltd. and Ranbaxy Laboratories Ltd. in June when Merck's patents expired. Companies receiving ...